It is plausible that Wnt3a levels may also be considered as a biomarker of enhanced virus infection; however, extensive investigation on the dynamic regulation of Wnt3a expression during viral infection using patient plasma is necessary. This evidence concerns the gene WNT3A and viral infectious disease.